Kathleen M Bergin, Emily K Black, Andrea L Murphy, Deborah V Kelly, Kyle John Wilby
{"title":"Pharmacists' acceptability of provision of sexually transmitted infection services: a scoping review.","authors":"Kathleen M Bergin, Emily K Black, Andrea L Murphy, Deborah V Kelly, Kyle John Wilby","doi":"10.1093/ijpp/riaf039","DOIUrl":"10.1093/ijpp/riaf039","url":null,"abstract":"<p><strong>Objective: </strong>Pharmacists are taking on more roles in helping to close the gap in care for sexually transmitted infection (STI) management services. The acceptability of pharmacists to perform these services is not yet well understood. The objective of this review was to map, characterize, and explicate the acceptability of pharmacist-delivered STI services.</p><p><strong>Methods: </strong>A scoping review was conducted. Three databases (PubMed, Embase, and CINAHL) were searched up to July 2024 for articles relating to the acceptability of pharmacists to independently assess and manage issues relating to STIs. The results were then mapped to the theoretical framework of acceptability (TFA).</p><p><strong>Key findings: </strong>A total of 2181 publications were identified. 22 studies met inclusion criteria and assessed at least one outcome aligning within the constructs of the TFA. Services relating to pre-exposure prophylaxis prescribing, point-of-care testing, chlamydia (and gonorrhea) testing and treatment, and human papillomavirus vaccine prescribing were identified. The overall acceptability of pharmacist-delivered STI services was high across the constructs of the TFA.</p><p><strong>Conclusions: </strong>This review outlines that the acceptability of pharmacists to provide STI management is high and pharmacists are willing to take on accountability for these services. Pharmacists believe that they have a moral obligation to improve the health and wellbeing of their patients, while, decreasing the burden on the broader health care system.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"369-377"},"PeriodicalIF":1.8,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144284319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Saioa Domingo-Echaburu, Zuriñe Abajo, Usue Elizondo-Alzola, Juan Francisco Rangel-Mayoral, Almudena Rojas-Albarrán, Vladimir Akhrimenko, Gorka Orive, Unax Lertxundi
{"title":"Knowledge, attitude, and practice about the environmental impact of pharmaceuticals among hospital pharmacists in Spain: a cross-sectional survey.","authors":"Saioa Domingo-Echaburu, Zuriñe Abajo, Usue Elizondo-Alzola, Juan Francisco Rangel-Mayoral, Almudena Rojas-Albarrán, Vladimir Akhrimenko, Gorka Orive, Unax Lertxundi","doi":"10.1093/ijpp/riaf034","DOIUrl":"10.1093/ijpp/riaf034","url":null,"abstract":"<p><strong>Objectives: </strong>The environmental impact of pharmaceuticals is an issue of growing concern. We aimed to assess the degree of knowledge, attitude, and practice about the environmental impact of pharmaceuticals among hospital pharmacists in Spain.</p><p><strong>Methods: </strong>A cross-sectional descriptive study was conducted using a self-administered online questionnaire. A total of 149 hospital pharmacists out of 4452 answered the survey, yielding a response rate of 3.3%.</p><p><strong>Key findings: </strong>The results showed good knowledge about carbon footprint of metered dose inhalers and the Spanish medicines take-back scheme, while there was room for improvement in the knowledge in some areas (only 43% of respondents knew the concept \"One Health\"). Although the attitudes towards the issue were positive (average score >8 out of 10 for most questions), environmental criteria are rarely considered when developing drug formularies (11.4%) or drug procurement (14.8%).</p><p><strong>Conclusions: </strong>We believe there is an urgent need to raise awareness and knowledge among hospital pharmacists about the negative environmental impact of pharmaceuticals to tackle this problem.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"448-452"},"PeriodicalIF":1.5,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144179894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pharmaceuticals in drinking water: a scoping review to raise pharmacists' public health and environmental awareness on contamination in groundwater, surface water, and other sources.","authors":"Mandy Coderre, Ann-Sophie Fortin, Louis-David Morency, Juliette Roy, Caroline Sirois","doi":"10.1093/ijpp/riaf038","DOIUrl":"10.1093/ijpp/riaf038","url":null,"abstract":"<p><strong>Objective: </strong>To summarize knowledge on medications and medication-disinfection byproducts-compounds formed when pharmaceutical contaminants react with disinfectants-found in drinking water and its sources (effluents, surface water, groundwater), aiming to raise awareness and empower pharmacists to implement best practices for improving public health and reducing environmental impact.</p><p><strong>Methods: </strong>A scoping review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. Data were retrieved from Medline and Embase between 2005 and 2023 using keywords related to drinking water, pharmaceutical waste, and water purification. Articles had to focus on human medication use and originate from North America and Europe. Data on types of medications, concentrations found in drinking water or its sources, and types of byproducts were extracted, and a narrative synthesis was written.</p><p><strong>Key findings: </strong>Forty-five articles were included. Among pre-defined classes, antihypertensives, analgesics, antibiotics, and psychotropic medications were most frequently found. The most commonly identified medications included carbamazepine, diclofenac, ibuprofen, and acetaminophen/paracetamol. Traces of medications were present in many water sources, with higher concentrations near pharmaceutical industries. Some medications, like carbamazepine, persist in the environment for extended periods. Although not necessarily found in drinking water, medication-disinfection byproducts can be toxic, and further evidence is required to assess their risk.</p><p><strong>Conclusions: </strong>Many medications are found in drinking water and its sources, highlighting the need for pharmacists to consider their public health impact. Best practices, such as prescribing only when necessary, deprescribing, social/green prescribing, and opting for environmentally friendly alternatives, should be enforced.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"360-368"},"PeriodicalIF":1.8,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144191808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Predicting medicine related harm in older adults post discharge: an Australian feasibility study.","authors":"Phu Sabei Shwe, Amy Page, H Laetitia Hattingh, Nikesh Parekh, Khalid Ali, Chakravarthi Rajkumar","doi":"10.1093/ijpp/riaf044","DOIUrl":"10.1093/ijpp/riaf044","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the feasibility of identifying older patients at risk of medicine-related harm (MRH) at hospital discharge using a MRH risk-prediction tool, follow them up in the community, and identify the incidence and severity of MRH causing readmission to hospital.</p><p><strong>Methods: </strong>Patients who were over 65 years admitted to a general medical ward were recruited 48 hours prior to discharge from two hospitals in Queensland, Australia, 19 October 2020 to 15 March 2021. Ward pharmacists predicted the likelihood of MRH post-discharge and confidence in this decision. Participants were followed up until eight weeks post-discharge; data were extracted from hospital records. An expert panel of five senior clinicians assessed structured case summaries of participants who attended hospital within the follow-up 56-day period to determine MRH. MRH risk was assessed using the PRIME (Prospective study to develop a model to stratify the RIsk of Medication-related harm in hospitalized Elderly patients) tool.</p><p><strong>Key findings: </strong>All 39 patients approached consented; 31 participated in follow-up phone calls. Of these 39, 23 (59%) had one or more readmission within 56 days. Six readmissions in five participants were associated with MRH. Of the MRH, three were definite adverse drug reactions while one was due to medicine non-adherence. MRH was potentially preventable in four cases.</p><p><strong>Conclusion: </strong>Outcomes show it is feasible to recruit and complete follow-up of older patients in the Australian healthcare system to examine the burden of MRH and use of a risk identification tool.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"417-423"},"PeriodicalIF":1.5,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rasha M Arabyat, Eman A Hammad, Samah Al-Shatnawi, Haneen A Amawi
{"title":"Determinants of healthcare-seeking behavior from pharmacies and associated out-of-pocket spending: a population-based study from Jordan.","authors":"Rasha M Arabyat, Eman A Hammad, Samah Al-Shatnawi, Haneen A Amawi","doi":"10.1093/ijpp/riaf045","DOIUrl":"10.1093/ijpp/riaf045","url":null,"abstract":"<p><strong>Objectives: </strong>To identify determinants of healthcare seeking from pharmacies in Jordan using Andersen's healthcare utilization model. Additionally, an analysis of the out-of-pocket (OOP) spending was performed.</p><p><strong>Methods: </strong>An analysis of the Jordan Population and Family Health Survey (JPFHS), a nationally representative survey of Jordanian households, was conducted. Weighted hierarchical multiple logistic regression models were built to specify important variables related to seeking care from pharmacies in Jordan compared to other outpatient healthcare facilities.</p><p><strong>Key findings: </strong>Out of 12,716 respondents, 19.1% reported visiting a pharmacy within the past 4 weeks. The associated average OOP spending was JD17.7, significantly lower than for other outpatient healthcare facilities (JD 24.8). Among predisposing characteristics, females were more inclined to visit a pharmacy compared to males (adjusted odds ratio [AOR] = 1.16; 95% CI: 1.02-1.33). Positive enabling factor included residing in northern (AOR: 1.85; 95% CI: 1.19-2.87) or southern regions (AOR: 3.66; 95% CI: 1.57-8.56) compared to center regions of Jordan. The cost of transportation was a negative enabling factor (AOR: 0.24; 95% CI: 0.15-0.40). Significant need factors that increased the odds of visiting a pharmacy included seeking care for fever/diarrhea (AOR: 1.99; 95% CI: 1.04-3.80). Preventive care/vaccination (AOR: 0.18; 95% CI: 0.05-0.68) decreased the odds of visiting a pharmacy.</p><p><strong>Conclusion: </strong>The geographical location of a pharmacy, as indicated by transportation costs and region, significantly influences visiting patterns. Pharmacies appeared to be convenient and accessible for managing minor ailments and they offer significant potential for cost savings. To enhance pharmacies' contribution to public health, the integration of new services is strongly recommended.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"401-408"},"PeriodicalIF":1.5,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144199056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kamran Abbasi, Parveen Ali, Virginia Barbour, Marion Birch, Inga Blum, Peter Doherty, Andy Haines, Ira Helfand, Richard Horton, Kati Juva, Jose F Lapena, Robert Mash, Olga Mironova, Arun Mitra, Carlos Monteiro, Elena N Naumova, David Onazi, Tilman Ruff, Peush Sahni, James Tumwine, Carlos Umaña, Paul Yonga, Chris Zielinski
{"title":"Ending nuclear weapons, before they end us†.","authors":"Kamran Abbasi, Parveen Ali, Virginia Barbour, Marion Birch, Inga Blum, Peter Doherty, Andy Haines, Ira Helfand, Richard Horton, Kati Juva, Jose F Lapena, Robert Mash, Olga Mironova, Arun Mitra, Carlos Monteiro, Elena N Naumova, David Onazi, Tilman Ruff, Peush Sahni, James Tumwine, Carlos Umaña, Paul Yonga, Chris Zielinski","doi":"10.1093/ijpp/riaf032","DOIUrl":"10.1093/ijpp/riaf032","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"357-359"},"PeriodicalIF":1.5,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144093688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ann Helen Jakobsen, Noriko Sato, Timothy F Chen, Kenji Fujita, Lars Småbrekke, Kjell H Halvorsen
{"title":"Development of quality indicators for a community pharmacy setting.","authors":"Ann Helen Jakobsen, Noriko Sato, Timothy F Chen, Kenji Fujita, Lars Småbrekke, Kjell H Halvorsen","doi":"10.1093/ijpp/riaf030","DOIUrl":"10.1093/ijpp/riaf030","url":null,"abstract":"<p><strong>Objectives: </strong>Community pharmacies in Norway offer accessible healthcare services that require monitoring. Relevant and realistic quality indicators (QIs) must be developed to establish standards. This study aimed to establish consensus on healthcare quality measures in a community pharmacy setting by implementing two distinct approaches.</p><p><strong>Methods: </strong>A comprehensive multi-phase research design was implemented to identify, define, and select potential QIs for community pharmacies. Potential QIs were identified and nominated from workshops, focus groups, and literature. Thirteen panellists were recruited for a modified Delphi study over two rounds. We used the RAND/UCLA Appropriateness Method (RAM) panel median ratings and disagreement index (DI) to assess appropriateness and disagreement and define consensus.</p><p><strong>Key findings: </strong>We identified 192 QIs from workshops, focus groups and literature searches. After duplicates were removed and QIs with similar wording were merged, 137 QIs were nominated for the first Delphi round. The panellists deemed 61 appropriate, two inappropriate and excluded six QIs in the first round. The remaining 68 QIs were assessed in Round 2, where 23 achieved consensus as appropriate without disagreement. After DI was calculated, the number of QIs categorized as appropriate without disagreement after Round 1 and 2 was 34 and 10, respectively.</p><p><strong>Conclusion: </strong>This study demonstrates the use of the RAM combined with the DI to establish consensus on healthcare quality measures, i.e. QIs for community pharmacy services. Our findings indicate that the number of QIs considered acceptable is strongly impacted by the method chosen to handle disagreement in the ratings. Incorporating DI and conventional RAM disagreement calculations reduced the number of QIs deemed acceptable by half.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"386-392"},"PeriodicalIF":1.5,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ekta Punj, Catherine Atkin, Christian Subbe, Elizabeth Sapey
{"title":"Availability of pharmacy services within acute medicine: analysis from the Society for Acute Medicine Benchmarking Audit 2022.","authors":"Ekta Punj, Catherine Atkin, Christian Subbe, Elizabeth Sapey","doi":"10.1093/ijpp/riaf036","DOIUrl":"10.1093/ijpp/riaf036","url":null,"abstract":"<p><strong>Objectives: </strong>Patients seen in acute medicine services are at high risk of medication errors and subsequent harm. Pharmacy services within acute medicine or emergency departments have been shown to reduce medication errors and improve patient outcomes. However, there is a limited understanding of the national provision of pharmacy services within acute medicine. We aimed to evaluate the current availability of pharmacy services for acute medicine patients in the UK.</p><p><strong>Methods: </strong>Data were collected through an organizational survey of acute medicine departments nationally in June 2022. Questions aimed to evaluate the organization and availability of pharmacy services necessary to meet national guidance regarding medication reconciliation for acute admissions.</p><p><strong>Key findings: </strong>Across 129 acute hospitals in the UK, 98% utilized pharmacy services for medicines reconciliation on the acute medical unit, however, only 36% of hospitals had access to these services from 9 am to 5 pm on the weekend, and only 16% had access throughout the out of hours period (Monday-Sunday, 5 pm-9 am). Availability of out-of-hours services did not appear to be related to hospital size (Chi-square P = .94). Pharmacy services were provided in the emergency department in 29% of hospitals, with only 12% providing 24/7 coverage.</p><p><strong>Conclusions: </strong>There is considerable variation in pharmacy services accessible within acute medicine services nationally. Further research is required to understand this variability, its impact on clinical outcomes, and how this could best be addressed within acute medicine.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"424-430"},"PeriodicalIF":1.5,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144274842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rizah Anwar Assadi, Semira Beshir, Aliasgar Shahiwala, Mirza Baig
{"title":"A narrative review of preceptor roles and models of precepting in pharmacy practice experiential learning: a UAE perspective.","authors":"Rizah Anwar Assadi, Semira Beshir, Aliasgar Shahiwala, Mirza Baig","doi":"10.1093/ijpp/riaf057","DOIUrl":"https://doi.org/10.1093/ijpp/riaf057","url":null,"abstract":"<p><strong>Objectives: </strong>Pharmacy preceptors are pivotal in shaping pharmacy education by bridging theoretical knowledge with clinical practice. This review synthesizes the literature on pharmacy preceptor roles, responsibilities, and precepting models while exploring the unique challenges and opportunities in the UAE healthcare context. The evolving focus on clinical pharmacy within the United Arab Emirates highlights the necessity of tailored precepting strategies to meet local needs.</p><p><strong>Methods: </strong>A comprehensive literature review was conducted using Scopus, PubMed, and Google Scholar. Search terms focused on pharmacy preceptor roles, responsibilities, precepting models, and challenges and strategies for overcoming them. Thematic analysis was employed to extract and categorize key insights, particularly those relevant to the United Arab Emirates.</p><p><strong>Key findings: </strong>The review identifies the four core roles of preceptors: direct instruction, modelling, coaching, and facilitating, as defined by the American Society of Health-System Pharmacists. It highlights global and UAE-specific challenges, such as preceptor shortages, cultural barriers, and the need for structured mentorship programmes. Innovative precepting models, including Peer-Assisted Learning and the Layered Learning Practice Model, are discussed for their potential adaptability to the UAE's healthcare system.</p><p><strong>Conclusions: </strong>Addressing the challenges faced by pharmacy preceptors in the United Arab Emirates requires a multi-faceted approach, including ongoing training, institutional support, and customized precepting strategies. By combining global best practices with local contextualization, the United Arab Emirates can enhance pharmacy education and align it with its healthcare priorities.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144690183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}